Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,899.60
(
0.11%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
94.20
(
-0.86%
)
Bitcoin
77,583.59
(
1.64%
)
News Focus
News Focus

Replies to post #167 on Cardiol Therapeutics Inc (CRDL)

Replies to #167 on Cardiol Therapeutics Inc (CRDL)
icon url

Tiger Money

06/18/24 11:58 AM

#168 RE: Sirpeter #167

Nice
icon url

Tiger Money

06/20/24 10:46 AM

#169 RE: Sirpeter #167

$1 bid here if my $1.50’s get filled
icon url

MahinAgency

11/06/24 2:52 PM

#216 RE: Sirpeter #167

NASDAQ: $CRDL
 Cardiol Therapeutics recently reported encouraging outcomes from its Phase II MAvERIC trial of CardiolRx, an ultra-pure oral cannabidiol formulation for recurrent pericarditis.

The 12-month price target is $10
Bullish
Bullish